## Teaching

 + [R Notebooks](https://github.com/Oncostat/R_notebooks)
 + INSERM workshop 2017: predictionPenalized [[link](https://github.com/Oncostat/predictionPenalized)]

## Software

### R packages and code

 + Biomarker selection in penalized regression models [![CRAN_Status_Badge](https://www.r-pkg.org/badges/version/biospear)](https://cran.r-project.org/package=biospear) [[link](https://github.com/Oncostat/biospear)]
 + Parametric Frailty Models [![CRAN_Status_Badge](https://www.r-pkg.org/badges/version/parfm)](https://cran.r-project.org/package=parfm) [[link](https://github.com/Oncostat/parfm)]
 + Evaluation of Failure Time Surrogate Endpoints in Individual Patient Data Meta-Analyses [![CRAN_Status_Badge](https://www.r-pkg.org/badges/version/surrosurv)](https://cran.r-project.org/package=surrosurv) [[link](https://github.com/Oncostat/surrosurv)]
 + Drop the losers with historical control group [[link](https://github.com/Oncostat/DTLHC)]
 + Group-sequential-adaptive-designs-in-series-of-time-to-event-randomized-trials-in-rare-diseases [[link](https://github.com/Oncostat/Group-sequential-adaptive-designs-in-series-of-time-to-event-randomized-trials-in-rare-diseases)]
 + Mixed Effect Multivariate Continuation Ratio model [[link](https://github.com/Oncostat/POP1)]
 + Estimation of the probability of patients having a time to progression ratio superior to a given threshold [[link](https://github.com/Oncostat/TTPratio)]

 
### SAS macros
 + Dual-Agent Bayesian Continual Reassessment Method [[link](https://github.com/Oncostat/CRM2dim)]

### Others
 + BenchmarkNCVTools [[link](https://github.com/Oncostat/BenchmarkNCVTools)]

## Supplementary Material of Publication

 + PrognosTILs application [[link](https://github.com/Oncostat/PrognosTILs)]
 
## Other

 + ...
